Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1046372210 | 10463722 | 10 | F | 20140719 | 20160324 | 20140919 | 20160331 | EXP | PHHY2014CA084758 | NOVARTIS | 67.35 | YR | F | Y | 84.10000 | KG | 20160331 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1046372210 | 10463722 | 1 | PS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | 100 UG, ONCE/SINGLE | 19667 | 100 | UG | 1X | |||||||
| 1046372210 | 10463722 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (EVERY 28 DAYS) | 0 | 30 | MG | /month | |||||||
| 1046372210 | 10463722 | 3 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, TIW (EVERY 3 WEEKS) | 0 | 30 | MG | Q3W |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1046372210 | 10463722 | 1 | Neuroendocrine tumour |
| 1046372210 | 10463722 | 2 | Neuroendocrine tumour |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1046372210 | 10463722 | HO |
| 1046372210 | 10463722 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1046372210 | 10463722 | Back pain | |
| 1046372210 | 10463722 | Blood glucose increased | |
| 1046372210 | 10463722 | Blood pressure increased | |
| 1046372210 | 10463722 | Body temperature decreased | |
| 1046372210 | 10463722 | Cough | |
| 1046372210 | 10463722 | Discomfort | |
| 1046372210 | 10463722 | Dyspnoea exertional | |
| 1046372210 | 10463722 | Fatigue | |
| 1046372210 | 10463722 | Full blood count decreased | |
| 1046372210 | 10463722 | Headache | |
| 1046372210 | 10463722 | Heart rate decreased | |
| 1046372210 | 10463722 | Inappropriate schedule of drug administration | |
| 1046372210 | 10463722 | Malaise | |
| 1046372210 | 10463722 | Pneumonia | |
| 1046372210 | 10463722 | Pulmonary oedema | |
| 1046372210 | 10463722 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1046372210 | 10463722 | 1 | 20140704 | 20140704 | 0 | |
| 1046372210 | 10463722 | 2 | 20140719 | 0 | ||
| 1046372210 | 10463722 | 3 | 201601 | 0 |